Experimental drug brincidofovir targets Hard-to-Treat lymphomas
Disease control
Terminated
This study tests an experimental drug called brincidofovir in people with lymphoma (a type of blood cancer) that has returned or not improved after standard treatments. The trial has two parts: first, finding a safe dose in up to 18 people with various lymphomas, then testing tha…
Phase: PHASE1, PHASE2 • Sponsor: SymBio Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC